UPLIZNA 100 MG per 10 ML Injection
- RxCUI
- 2373960
- RxNorm name
- UPLIZNA 100 MG per 10 ML Injection
- Display name
- UPLIZNA 100 MG per 10 ML Injection
- Full name
- UPLIZNA 100 MG per 10 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761142 | Uplizna | inebilizumab-cdon | 351(a) | Rx | 2026-06-01 |
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UPLIZNA | INEBILIZUMAB | Horizon Therapeutics USA, Inc. | 834db232-afb0-4dcf-93e0-009ce8245c20 | 2025-12-11 | Warnings, Adverse reactions | 2373960 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 834db232-afb0-4dcf-93e0-009ce8245c20 | UPLIZNA 100 MG per 10 ML Injection | SY | 9 | These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 2020 | 20251211 |
| 834db232-afb0-4dcf-93e0-009ce8245c20 | 10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna] | SBD | 9 | These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 2020 | 20251211 |
| 834db232-afb0-4dcf-93e0-009ce8245c20 | UPLIZNA 100 MG in10 ML Injection | PSN | 9 | These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 2020 | 20251211 |
| 834db232-afb0-4dcf-93e0-009ce8245c20 | 10 ML Uplizna 10 MG/ML Injection | SY | 9 | These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 2020 | 20251211 |